Please login to the form below

Not currently logged in
Email:
Password:

Genzyme’s Henk Doude van Troostwijk joins Raptor Pharmaceutical

US pharma company will also set up European headquarters in the Netherlands

Raptor Pharmaceutical has appointed Henk Doude van Troostwijk as general manager of European commercial operations.

He will be responsible for building and managing Raptor's presence in Europe following the California-based company's decision to establish European headquarters in Leiden, the Netherlands.

Doude van Troostwijk will join the company on April 15 from Sanofi's Genzyme business, where he most recently served as business unit director, oncology, for haematology and transplantation in Northern Europe.

Prior to that he held various roles at Bioenvision, MSD, Bristol-Myers Squibb and Nycomed.

At Raptor his initial focus will be on preparing for the launch and marketing of the company's RP103, an orphan treatment for cell toxicity condition nephropathic cystinosis that is currently being considered for approval by European regulatory authorities.

Patrick Reichenberger, vice president of commercial operations, said: "We are very excited to have Henk join our team to lead the commercial operations in Europe.

“His expertise in gaining market access, working with orphan products and leading commercial teams will be critical as we prepare for the potential launch of RP103 in Europe."

2nd April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics